Encompass Health reaffirms FY2025 guidance ahead of investor meetings

Encompass Health Corp

Reiterated FY2025 net operating revenue $5,850M-$5,925M.
Adjusted EBITDA reaffirmed at $1,185M-$1,220M.
Adjusted EPS from continuing ops reaffirmed at $4.85-$5.10.
Senior management to meet investors on June 4 and June 18, 2025.

item 7.01

Source: SEC EDGAR

accession 0000785161-25-000028

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.